Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Pharminackx from Alken, company number BE0744671869, closed financial year 2025 with a result of € 10,599 after tax. For that financial year Pharminackx recorded a gross margin of € 21,862 and equity of € 76,204. Compared with financial year 2024, the result moved from € 13,539 to € 10,599. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 76,204
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,599
▼ 22% vs 2024
Profit after tax over the fiscal year.
€ 1,058
▲ € 1,014 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 71,204.
People and assets in 2025
€ 1,983
▼ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 465,787
▼ 7% vs 2024
€ 32,811 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 199
▼ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,901
▲ 83% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 32,458 | € 31,636 | € 26,210 | € 21,862 | ▼ 17% |
| Profit after taxes | € 8,732 | € 17,459 | € 13,539 | € 10,599 | ▼ 22% |
| Equity | € 34,606 | € 52,065 | € 65,604 | € 76,204 | ▲ 16% |
| Total debts | € 924,234 | € 881,309 | € 873,744 | € 864,213 | ▼ 1% |
| Cash | € 3,779 | € 1,943 | € 44 | € 1,058 | ▲ € 1,014 |
| Retained profit | € 29,606 | € 47,065 | € 60,604 | € 71,204 | ▲ 17% |
| Bank debt | € 562,061 | € 530,319 | € 498,237 | € 465,787 | ▼ 7% |
| Balance sheet total | € 958,840 | € 933,374 | € 939,349 | € 940,417 |
Key figures of Pharminackx, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharminackx?
What happened at Pharminackx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10,599 (▼ 22% vs 2024). Source: NBB ↗
- New establishment in Alken. KBO
- ANKE HENDRICKX became a director. NBB
- Ine Hendrickx became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 8,732 profit in 2022 to € 10,599 profit in 2025.
Paid € 20,154 in corporate taxes since 2022.
Best year ever: 2023, with € 17,459 profit.
Management
Behind Pharminackx are ANKE HENDRICKX and Ine Hendrickx. It owns 100% of Apotheek Terkoest itself.
Directors
According to the 2025 annual accounts
ANKE HENDRICKX
Director
Also active at: Apoteek Van Elewyck - Sint Hubertus, Management Hendrickx-Van Elewyck
since 2020
since 2020
Establishments
Establishment units
Physical locations of this company
O. L. Vrouwstraat 92
3570 Alken
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0744.671.869
- VAT number
- BE 0744.671.869
- Registered office
- O. L. Vrouwstraat 92, 3570 Alken
- Names & denominations
- Pharminackx
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 March 2020
- Peppol
- Active · Active since 12 Sept 2025
- Activities · NACE
Activiteiten van holdings
Holdings